All Articles on Flu
Researchers begin trial for high-dose flu vaccineKPWHRI is seeking volunteers ages 50 to 64 who have not received this season’s flu vaccine to join the trial.
KPWHRI contributes to new flu vaccine effectiveness resultsInterim data for the 2023-2024 flu season shows that the vaccine has protected all age groups.
Researchers begin trial for mRNA flu vaccineThe investigational vaccine is in the third phase of trials and targets flu strains expected to circulate this winter.
KPWHRI begins new phase of flu surveillanceKPWHRI receives $10 million to continue vaccine effectiveness research for flu, COVID-19, and other respiratory diseases
The impact of vaccines: Millions of lives savedVaccinations in 112 countries prevented an estimated 50 million deaths over the last 20 years.
COVID-19 and flu: What to expect this winterAnswers to 4 questions about COVID-19 and this season's flu, from KPWHRI's Michael Jackson, PhD, MPH.
Flu shot Q & A: Does COVID-19 change our approach?KPWHRI’s Michael L. Jackson, PhD, MPH, talks about influenza vaccine research in the age of the pandemic.
Land Acknowledgment
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.